Harvard Pilgrim Launching Closed Formulary, Weighing Specialty Drug Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
The mid-size payer’s move to a closed formulary represents a big change from years of offering relatively open formularies and comes as the insurer is feeling substantial pressure to control costs, Chief Medical Officer Michael Sherman explained in an interview.